Mylan Suffers Biggest Drop in Almost Two Decades Amid Drug Pain

World News: . []

Mylan Suffers Biggest Drop in Almost Two Decades Amid Drug PainMylan, one of the world’s biggest makers of generic drugs, has faced manufacturing problems, competition and declining prices that have created “unprecedented volatility,” Chief Executive Officer Heather Bresch said on a call with investors after reporting first-quarter results. “There is a tremendous amount of work being done” by the strategic committee, which will provide an update in the “near term,” Bresch said on a conference call after the company reported first-quarter earnings. Investors, however, were in no mood to wait, and Mylan shares fell 24 percent to $21.53.


Read More: LINK 

Published: .

Search for other references to "mylan" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us